Skip to main content

Medication Non-Adherence in the Elderly

How Big is the Problem?

Drugs & Aging volume 21, pages 793–811 (2004)Cite this article

Abstract

Adherence to medication is one of the most intriguing and complex behaviours demonstrated by patients. Non-adherence to a therapeutic regimen may result in negative outcomes for patients and may be compounded in populations with multiple morbidities which require multiple drug therapy. Such a population is exemplified by the elderly. However, non-adherence may not be more prevalent in older patients and there is no consensus in the literature that age is a predictor of poor adherence. Indeed, older patients may deliberately choose not to adhere to medication (intentional non-adherence) to avoid adverse effects. Furthermore, many of the studies on adherence lack commonality in terms of how adherence is measured, the definition of an ‘older’ patient and the range of disease states which have been examined. Adherence may also be affected by access to medications which may be restricted by the use of formularies or insurance programmes. However, non-adherence may represent a greater risk in older people resulting in poor disease control which may be compounded with multiple morbidity and polypharmacy.

A range of strategies have been implemented to try and improve adherence in this patient population. The use of forgiving drugs (those which have a prescribed dosage interval that is 50% or less the duration of drug action) may facilitate occasional lapses in drug-taking. Drug holidays (deliberate, supervised non-adherence for a fixed period of time) have been used in Parkinson’s disease to reduce adverse effects. Once-daily scheduling of drug administration may offer a pragmatic approach to optimising drug therapy in some patients; this may be supplemented through the use of compliance aids. What is increasingly apparent, however, is that the role of the patient (irrespective of age) is critical in decision-making about medication, together with communication between patients and healthcare professionals. This has been articulated through the concept of concordance which has been described as a therapeutic alliance between the patient and healthcare professional. In addition, interventions employed to improve adherence must be multifaceted, and together with practical approaches (reducing unnecessary drugs and simplifying dosage regimens), the patient perspective must be considered. Good adherence should be seen as a means of achieving a satisfactory therapeutic result and not as an end in itself.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Haynes RB. Determinants of compliance: the disease and the mechanics in treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore (MD): Johns Hopkins University Press, 1979: 3–18

    Google Scholar 

  2. Schaffer SD, Yoon S-JL. Evidence-based methods to enhance medication adherence. Nurse Pract 2001; 26: 50–4

    Article  Google Scholar 

  3. Haynes RB, Matteson ME, Garrity TF, et al. Management of patient compliance in the treatment of hypertension. Hypertension 1982; 4: 415–23

    Article  Google Scholar 

  4. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74

    Article  PubMed  CAS  Google Scholar 

  5. World Health Organisation (WHO). Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003

    Google Scholar 

  6. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme, 1997

  7. Jones G. Prescribing and taking medicines. BMJ 2003; 327: 819–20

    Article  PubMed  Google Scholar 

  8. Noncompliance with medications: an economic tragedy with important implications for health care reform. Baltimore (MD): The Task Force for Compliance, 1993

  9. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991; 48: 1978–88

    PubMed  CAS  Google Scholar 

  10. Wright EC. Non-compliance or how many aunts has Matilda? Lancet 1993; 342: 909–13

    Article  PubMed  CAS  Google Scholar 

  11. Morris LS, Schulz RM. Patient compliance: an overview. J Clin Pharm Ther 1992; 17: 283–95

    Article  PubMed  CAS  Google Scholar 

  12. Salzman C. Medication compliance in the elderly. J Clin Psychiatry 1995; 56Suppl. 1: 18–23

    PubMed  Google Scholar 

  13. Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care 1995; 11: 443–55

    Article  PubMed  CAS  Google Scholar 

  14. Morris LS, Schulz RM. Medication compliance: the patient’s perspective. Clin Ther 1993; 15: 593–606

    PubMed  CAS  Google Scholar 

  15. Nichol MB, Venturini F, Sung JCY. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33: 531–40

    Article  PubMed  CAS  Google Scholar 

  16. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32: 749–54

    Article  PubMed  CAS  Google Scholar 

  17. Sturgess IK, Hughes CM, McElnay JC, et al. Identifying non-compliance of elderly patients: a comparison of three methods. Pharm J 1998; 261: R14

    Google Scholar 

  18. Burnier M, Schneider MP, Chiolero A, et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335–41

    Article  PubMed  CAS  Google Scholar 

  19. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993; 72: 68–74D

    Article  Google Scholar 

  20. Raynor DK. Patient compliance: the pharmacist’s role. Int J Pharm Pract 1992; 1: 126–35

    Article  Google Scholar 

  21. Conner M, Norman P. The role of social cognition in health behaviours. In: Conner M, Norman P, editors. Predicting health behaviour. Buckingham: Open University Press, 1996

    Google Scholar 

  22. Rosenstock I. Why people use health services. Milbank Mem Fund Q 1966; 44: 94–124

    Article  PubMed  Google Scholar 

  23. Becker MH. The health belief model and sick role behaviour. Health Educ Monogr 1974; 2: 409–19

    Google Scholar 

  24. Wallston KA. Hocus-pocus, the focus isn’t strictly on locus: Rotter’s social learning theory modified for health. Cognit Ther Res 1992; 16: 183–99

    Article  Google Scholar 

  25. Bandura A. Self-efficacy: towards a unifying theory of behavioural change. Psychol Rev 1977; 84: 191–215

    Article  PubMed  CAS  Google Scholar 

  26. Fishbein M, Ajzen I. Belief, attitude, intention and behaviour: an introduction to theory and research. New York: Wiley, 1975

    Google Scholar 

  27. Azjen I. Attitudes, personality and behaviour. Milton Keynes: Open University Press, 1988

    Google Scholar 

  28. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985; 20: 28–37

    Article  Google Scholar 

  29. Costa Jr PT, McCrae RR. The NEO personality inventory-R: professional manual. Odessa (FL): Psychological Assessment Resources, 1992

    Google Scholar 

  30. Christensen AJ, Smith TW. Personality and patient adherence: correlated of the Five-Factor model in renal dialysis. J Behav Med 1995; 18: 305–13

    Article  PubMed  CAS  Google Scholar 

  31. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am 1989; 73: 1551–63

    PubMed  CAS  Google Scholar 

  32. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764–71

    Article  PubMed  CAS  Google Scholar 

  33. Weintraub M. Intelligent non-compliance with special emphasis on the elderly. Contemp Pharm Pract 1980; 4: 8–11

    Google Scholar 

  34. Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994; 9: 96–105

    Article  PubMed  CAS  Google Scholar 

  35. Mallion JM, Baguet JP, Siche JP. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens 1997; 16Suppl. 1: S75–80

    Google Scholar 

  36. Park DC, Morrell RW, Frieske D, et al. Medication adherence behaviours in older adults: effects of external cognitive supports. Psychol Aging 1992; 7: 252–6

    Article  PubMed  CAS  Google Scholar 

  37. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 2002; 36: 1532–9

    Article  PubMed  Google Scholar 

  38. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV subjects. AIDS Care 2000; 12: 387–98

    Article  PubMed  CAS  Google Scholar 

  39. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy non-compliance and patient characteristics, health-related quality of life and healthcare costs. Pharmacotherapy 2000; 20: 941–9

    Article  PubMed  CAS  Google Scholar 

  40. Farmer KC, Jacobs EW, Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther 1994; 16: 316–26

    PubMed  CAS  Google Scholar 

  41. Spiers MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995; 52: 985–90

    PubMed  CAS  Google Scholar 

  42. Cline CMJ, Bjorck-Linne AK, Israelsson BYA, et al. Noncompliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999; 1: 145–9

    Article  PubMed  CAS  Google Scholar 

  43. Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433–7

    Article  PubMed  CAS  Google Scholar 

  44. Jones JK, Gorkin L, Lian JF. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311: 293–5

    Article  PubMed  CAS  Google Scholar 

  45. Morrell RW, Park DC, Kidder DP, et al. Adherence to antihypertensive medications across the life span. Gerontologist 1997; 37: 609–19

    Article  PubMed  CAS  Google Scholar 

  46. Richardson MA, Simons-Morton B, Annegers JF. Effect of perceived barriers on compliance with antihypertensive medication. Health Educ Q 1993; 20: 489–503

    Article  PubMed  CAS  Google Scholar 

  47. Lau HS, Beuning KS, Postma-Lim E, et al. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci 1996; 18: 63–8

    Article  PubMed  CAS  Google Scholar 

  48. Owen SG, Friesen WT, Roberts MS, et al. Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 1985; 24: 313–20

    Article  PubMed  CAS  Google Scholar 

  49. Park DC, Hertzog C, Leventhal H, et al. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 1999; 47: 172–83

    PubMed  CAS  Google Scholar 

  50. Viller F, Guillemin F, Briancon S, et al. Compliance to drug treatment of patients rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999; 26: 2114–22

    PubMed  CAS  Google Scholar 

  51. Curtin RB, Svarstad BL, Andress D, et al. Differences in older versus younger hemodialysis patients’ non-compliance with oral medications. Geriatr Nephrol Urol 1997; 7: 35–44

    Article  PubMed  CAS  Google Scholar 

  52. Brewer NT, Chapman GB, Brownlee S, et al. Cholesterol control, medication adherence and illness cognition. Br J Health Psychol 2002; 7: 433–47

    Article  PubMed  Google Scholar 

  53. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455–61

    Article  PubMed  Google Scholar 

  54. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462–7

    Article  PubMed  Google Scholar 

  55. Hulka BS, Cassel JC, Kupper LL, et al. Communication, compliance and concordance between physicians and patients with prescribed medications. Am J Public Health 1976; 66: 846–53

    Google Scholar 

  56. Dolce JJ, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837–41

    Article  PubMed  CAS  Google Scholar 

  57. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14: 88–90

    Article  PubMed  Google Scholar 

  58. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7

    Article  PubMed  CAS  Google Scholar 

  59. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1987; 35: 539–45

    Article  Google Scholar 

  60. Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid: effects on therapy, costs and equity. N Engl J Med 1987; 317: 550–6

    Article  PubMed  CAS  Google Scholar 

  61. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325: 1072–7

    Article  PubMed  CAS  Google Scholar 

  62. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1997; 331: 650–5

    Article  Google Scholar 

  63. Bazargan M, Barbre AR, Hamm V. Failure to have prescriptions filled among black elderly. J Aging Health 1993; 5: 264–82

    Article  PubMed  CAS  Google Scholar 

  64. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7

    Article  PubMed  CAS  Google Scholar 

  65. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5

    Article  PubMed  CAS  Google Scholar 

  66. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med 1997; 157: 1921–9

    Article  PubMed  CAS  Google Scholar 

  67. Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–5

    Article  PubMed  CAS  Google Scholar 

  68. Cramer JA. Optimizing long-term patient compliance. Neurology 1995; 45Suppl. 1: S25–8

    PubMed  CAS  Google Scholar 

  69. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta analysis. Med Care 1998; 36: 1138–61

    Article  PubMed  CAS  Google Scholar 

  70. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Practice Suppl 1994; 73: 2–12

    CAS  Google Scholar 

  71. Stephenson BJ, Rowe BH, Haynes RB, et al. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 2779–81

    Article  PubMed  CAS  Google Scholar 

  72. Urquhart J. Patient compliance with crucial drug regimens: implications for prostate cancer. Eur Urology 1996; 29Suppl. 2: 124–31

    Google Scholar 

  73. Haynes RB, Gibson ES, Taylor DW, et al. Process versus outcome in hypertension: a positive result. Circulation 1982; 65: 28–33

    Article  PubMed  CAS  Google Scholar 

  74. Markowitz M. Eradication of rheumatic fever: an unfulfilled hope. Circulation 1970; 41: 1077–84

    Article  PubMed  CAS  Google Scholar 

  75. Mallion JM, Dutrey-Dupagne C, Vaur L, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patient with mild to moderate hypertension. J Hypertens 1996; 14: 137–44

    PubMed  CAS  Google Scholar 

  76. Rudd P, Ahmed S, Zachary V, et al. Issues in patient compliance: the search for therapeutic sufficiency. Cardiology 1992; 80Suppl. 1: 2–10

    Article  PubMed  Google Scholar 

  77. Feldman RG, Kaye JA, Lannon MC. Parkinson’s disease: follow-up after ‘drug holiday’. J Clin Pharmacol 1985; 26: 662–7

    Google Scholar 

  78. Bermejo F, Calandre L. Molina JA, et al. Long-lasting drug holiday in Parkinson’s disease. Adv Neurol 1986; 45: 503–6

    Google Scholar 

  79. Mayeux R, Stern Y, Mulvey K, et al. Reappraisal of temporary levodopa withdrawal (‘drug holiday’) in Parkinson’s disease. N Engl J Med 1985; 313: 124–38

    Article  Google Scholar 

  80. Corona T, Rivera C, Otero E, et al. A longitudinal study of the effects of an l-dopa drug holiday in the course of Parkinson’s disease. Clin Neuropharmacol 1995; 18: 325–32

    Article  PubMed  CAS  Google Scholar 

  81. Steinberg SK. Considerations in the implementation of drug holiday programs in long-term care facilities. Can Pharm J 1984; 117: 214–6

    PubMed  CAS  Google Scholar 

  82. Cramer JA. Enhancing patient compliance in the elderly: role of packaging aids and monitoring. Drugs Aging 1998; 12: 7–15

    Article  PubMed  CAS  Google Scholar 

  83. Hyland ME. Rationale for once-daily therapy in asthma: compliance issues. Drugs 1999; 58Suppl. 4: 1–6

    Article  PubMed  Google Scholar 

  84. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419–24

    Article  PubMed  CAS  Google Scholar 

  85. Horne R, Clatworthy J, Polmear A, et al. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life. J Hum Hypertens 2001; 15Suppl. 1: S65–8

    PubMed  Google Scholar 

  86. Wong BSM, Norman DC. Evaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinic. J Am Geriatr Soc 1987; 35: 21–6

    PubMed  CAS  Google Scholar 

  87. Murray MD, Birt JA, Manatunga AK, et al. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 1993; 27: 616–21

    PubMed  CAS  Google Scholar 

  88. Medication and compliance: major issues in elderly patients with mobility problems. Drugs Ther Perspect 2000; 15(6): 5–7

    Google Scholar 

  89. Konkle-Parker DJ. A motivational intervention to improve adherence to treatment of chronic disease. J Am Acad Nurse Pract 2001; 13: 61–8

    Article  PubMed  CAS  Google Scholar 

  90. Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999; 1: 477–81

    Article  PubMed  CAS  Google Scholar 

  91. Van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community. Drugs Aging 2003; 20: 229–40

    Article  PubMed  Google Scholar 

  92. Peterson AM, Takiya L, Finley R. Meta-analysis of trails of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657–65

    PubMed  Google Scholar 

  93. Windsor RA, Bailey WC, Richards JM, et al. Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health 1990; 80: 1519–21

    Article  PubMed  CAS  Google Scholar 

  94. Hussey RN. Overcoming the clinical barriers of low literacy and medication non-compliance among the elderly. J Gerontol Nurs 1991; 17: 27–9

    PubMed  CAS  Google Scholar 

  95. Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J Fam Pract 1992; 35: 61–5

    PubMed  CAS  Google Scholar 

  96. Edworthy SM, Devins GM, and the Patient Education Study Group. Improving medication adherence between appropriate and inappropriate utilization. J Rheumatol 1999; 26: 1793–801

    PubMed  CAS  Google Scholar 

  97. Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm 1995; 52: 2196–9

    PubMed  CAS  Google Scholar 

  98. Leirer VO, Morrow DG, Tanke ED, et al. Elders’ nonadherence: its assessment and medication reminding by voice mail. Gerontologist 1991; 31: 514–20

    Article  PubMed  CAS  Google Scholar 

  99. Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Managed Care 1997; 3: 1693–8

    CAS  Google Scholar 

  100. Stamler R, Stamler J, Civinelli J, et al. Adherence and blood pressure response to hypertension treatment. Lancet 1975; II: 1227–30

    Article  Google Scholar 

  101. Russell ML, Isull W, Probstfield JL. Examination of medical professions for counseling on medication adherence. Am J Med 1985; 78: 277–82

    Article  PubMed  CAS  Google Scholar 

  102. DiMatteo RM, Sherbourne CD, Hays RD, et al. Physicians’ characteristics influence patients’ adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993; 12: 93–102

    Article  PubMed  CAS  Google Scholar 

  103. Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient noncompliance in the managed care setting: the care of medical therapy for glaucoma. Med Care 1998; 36: 357–69

    Article  PubMed  CAS  Google Scholar 

  104. Say RE, Thomson R. The importance of patient preferences in treatment decisions-challenges for doctors. BMJ 2003; 357: 542–5

    Article  Google Scholar 

  105. Jaarsma T, Abu-Saad HH, Dracup K, et al. Self-care behavior of patients with heart failure. Scand J Caring Sci 2000; 14: 112–9

    Article  PubMed  CAS  Google Scholar 

  106. Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with ‘non-adherent’ patients: a qualitative study. Br J Gen Pract 2002; 52: 24–32

    PubMed  Google Scholar 

  107. Morse EV, Simon PM, Balson PM. Using experiential training to enhance health professionals’ awareness of patient compliance issues. Acad Med 1993; 68: 693–7

    Article  PubMed  CAS  Google Scholar 

  108. Garay-Savilla ME, Malacara JM, Gonzalez-Parada F, et al. The belief in conventional medicine and adherence to treatment in non-insulin-dependent diabetes mellitus patients. J Diabetes Complications 1998; 12: 239–45

    Article  Google Scholar 

  109. DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary 1995; 30: 596–605

    PubMed  CAS  Google Scholar 

  110. Williams GC, Rodin GC, Ryan RM, et al. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol 1998; 17: 269–76

    Article  PubMed  CAS  Google Scholar 

  111. De Young M. Research on the effects of pharmacist-patient communication in institutions and ambulatory care sites, 1969–1994. Am J Health Syst Pharm 1996; 53: 1277–91

    PubMed  Google Scholar 

  112. Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc 2002; 42: 36–43

    Article  Google Scholar 

  113. Kozma CM. Noncompliance with medication therapy: when does it make a difference in outcomes. Manag Care Interface 2002; 15: 30–1

    PubMed  Google Scholar 

  114. Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997; 58Suppl. 1: 11–4

    PubMed  Google Scholar 

Download references

Acknowledgements

Carmel Hughes is currently supported by a National Primary Care Career Scientist Award from the Research and Development Office, Northern Ireland. The author has no conflict of interest directly related to the preparation of this review.

Author information

Authors and Affiliations

  1. School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland

    Carmel M. Hughes

Authors
  1. Carmel M. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carmel M. Hughes.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hughes, C.M. Medication Non-Adherence in the Elderly. Drugs Aging 21, 793–811 (2004). https://doi.org/10.2165/00002512-200421120-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200421120-00004

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Medication Adherence
  • Poor Adherence
  • Adherence Behaviour
  • Drug Holiday